SIX-listed Alcon, a Switzerland-based global eye care company, has completed a CHF602m (US$750m) share repurchase programme.
In aggregate, 9,301,877 registered shares were acquired on the SIX Swiss Exchange, representing 1.9% of the current share capital of Alcon.
Alcon recently missed out on plans to acquire STAAR following shareholders rejecting its US$1.6bn...
Netherlands-based IGS GeboJagema, a global healthcare mould maker, has made two strategic acquisitions: ACH Solution, an Austrian specialist in silicone rubber injection moulds; and the medical device operations of FRP, a UK-based rapid prototyping specialist.
The acquisitions significantly expand IGS GeboJagema’s ability to serve medical device clients. They translate into faster cycle times, lower mould costs, and smoother scale-up. The end-to-end approach also shortens the lead time for production tools.
“These acquisitions reflect our commitment to making life easier for our clients,” says Herman Rusch, CEO of IGS GeboJagema.
Acquiring ACH Solution...
